Clinical Study

The Effect of 40-Hz Light Therapy on Amyloid Load in Patients with Prodromal and Clinical Alzheimer’s Disease

Table 1

Demographic, clinical, and PET data.

Subject no.123456Median [range]

Age (years)706773548580

Gender (F/M)FMMMMM(1/5)

CDR10.50.50.50.50.5

SOB5.53.522.51.52.5

MMSE192525272627

AD/MCIADADMCIADADAD(5/1)

Disease dur. (months)10392013

Pre-post scan duration (month)9.51.10.61.113.84.0

PiB SUVR:Mean [95 CI]

Visual pre3.132.121.272.391.671.18
Visual post3.412.101.392.141.611.22
Difference (%)9.0 %-1.3 %9.5 %-10.6 %-3.2 %4.0 %1.2 %

Vis. Ass pre2.832.101.452.071.891.34
Vis. Ass post3.211.991.581.841.921.35
Difference (%)13.4 %-5.0 %9.2 %-11.4 %1.7 %1.1 %1.5 %

Parietal pre2.732.802.382.942.541.74
Parietal post2.992.712.832.572.341.83
Difference (%)9.6 %-3.3 %18.9 %-12.6 %-7.9 %5.2 %4.4 %

Precuneus pre3.313.192.263.442.592.102.81
Precuneus post3.582.952.722.962.832.192.87
Difference (%)8.1 %-7.5 %20.0 %-13.8 %9.1 %4.4 %3.4 %

Post. Cing. Pre3.253.262.413.612.561.952.84
Post. Cing. Post3.543.192.943.092.632.122.92
Difference (%)8.8 %-2.3 %22.1 %-14.4 %2.8 %9.0 %4.3 %

Global pre2.872.572.002.692.191.61
Global post3.172.462.332.352.301.67
Difference (%)10.6 %-4.1 %16.5 %-12.55.4 %4.1 %

CDR: Clinical Dementia Rating; SOB: CDR sum-of-boxes; MMSE: minimental state examination; AD: Alzheimer’s disease; MCI, mild cognitive impairment; SUVR: standardized uptake value ratio; pre: before light stimulation; post: after light stimulation.